Results: 40
In this issue: Graphical Abstracts.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 723, doi. 10.1111/all.15236
- Publication type:
- Article
Correspondence to: Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1073, doi. 10.1111/all.15185
- By:
- Publication type:
- Article
The Ccl17 gene encoding TARC is synergistically transactivated by PU.1 and IRF4 driven by the mammalian common promoter in dendritic cells.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1054, doi. 10.1111/all.15184
- By:
- Publication type:
- Article
Mast cells partly contribute to allergic enteritis development: Findings in two different mast cell‐deficient mice.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1051, doi. 10.1111/all.15182
- By:
- Publication type:
- Article
COVID‐19 vaccines tolerated in patients with paclitaxel and docetaxel allergy.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1048, doi. 10.1111/all.15178
- By:
- Publication type:
- Article
The emerging pathogen Paecilomyces variotii ‐ a novel and important fungal allergen source.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1045, doi. 10.1111/all.15176
- By:
- Publication type:
- Article
GATA‐3 and T‐bet as diagnostic markers of non‐esophageal eosinophilic gastrointestinal disease.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1042, doi. 10.1111/all.15171
- By:
- Publication type:
- Article
Direct oral penicillin challenge for penicillin allergy delabeling as a health services intervention: A multicenter cohort study.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1038, doi. 10.1111/all.15169
- By:
- Publication type:
- Article
The NLRP3 inflammasome inhibitor, OLT1177<sup>®</sup>, ameliorates experimental allergic asthma in mice.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1035, doi. 10.1111/all.15164
- By:
- Publication type:
- Article
Platelet‐activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy?
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1032, doi. 10.1111/all.15161
- By:
- Publication type:
- Article
The cannabinoid WIN55212‐2 suppresses effector T‐cell responses and promotes regulatory T cells in human tonsils.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1029, doi. 10.1111/all.15160
- By:
- Publication type:
- Article
Monensin induces selective mast cell apoptosis through a secretory granule‐mediated pathway.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1025, doi. 10.1111/all.15157
- By:
- Publication type:
- Article
Recurrence of anaphylaxis: A systematic review of observational studies.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1020, doi. 10.1111/all.15156
- By:
- Publication type:
- Article
Engineered IL‐10: A matter of affinity.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1067, doi. 10.1111/all.15132
- By:
- Publication type:
- Article
Pros and cons: Should allergen immunotherapy be considered in all patients with allergic asthma?
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1070, doi. 10.1111/all.15123
- By:
- Publication type:
- Article
Neuron−macrophage interaction in the healing process of the skin.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1064, doi. 10.1111/all.15122
- By:
- Publication type:
- Article
Medical algorithm: Management of C1 inhibitor hereditary angioedema.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1060, doi. 10.1111/all.15115
- By:
- Publication type:
- Article
T‐cell subsets in the skin and their role in inflammatory skin disorders.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 827, doi. 10.1111/all.15104
- By:
- Publication type:
- Article
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 734, doi. 10.1111/all.15090
- By:
- Publication type:
- Article
Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 812, doi. 10.1111/all.15074
- By:
- Publication type:
- Article
IL‐37 regulates allergic inflammation by counterbalancing pro‐inflammatory IL‐1 and IL‐33.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 856, doi. 10.1111/all.15072
- By:
- Publication type:
- Article
Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 897, doi. 10.1111/all.15071
- By:
- Publication type:
- Article
Management of allergic diseases in pregnancy.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 798, doi. 10.1111/all.15063
- By:
- Publication type:
- Article
Call for emergency action to limit global temperature increases, restore biodiversity and protect health: Wealthy nations must do much more, much faster.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 730, doi. 10.1111/all.15059
- By:
- Publication type:
- Article
Direct platelet adhesion potentiates group 2 innate lymphoid cell functions.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 843, doi. 10.1111/all.15057
- By:
- Publication type:
- Article
From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 778, doi. 10.1111/all.15056
- By:
- Publication type:
- Article
High‐dose pollen intralymphatic immunotherapy: Two RDBPC trials question the benefit of dose increase.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 883, doi. 10.1111/all.15042
- By:
- Publication type:
- Article
Secretoglobins in the big picture of immunoregulation in airway diseases.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 767, doi. 10.1111/all.15033
- By:
- Publication type:
- Article
Engineering a safe monoclonal anti‐human IL‐2 that is effective in a murine model of food allergy and asthma.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 933, doi. 10.1111/all.15029
- By:
- Publication type:
- Article
Open‐label follow‐on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 991, doi. 10.1111/all.15027
- By:
- Publication type:
- Article
IRE1 and PERK signaling regulates inflammatory responses in a murine model of contact hypersensitivity.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 966, doi. 10.1111/all.15024
- By:
- Publication type:
- Article
Prevention of infant eczema by neonatal Bacillus Calmette‐Guérin vaccination: The MIS BAIR randomized controlled trial.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 956, doi. 10.1111/all.15022
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 717, doi. 10.1111/all.14920
- Publication type:
- Article
Low oxygen levels decrease adaptive immune responses and ameliorate experimental asthma in mice.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 870, doi. 10.1111/all.15020
- By:
- Publication type:
- Article
Identification of novel biomarkers to distinguish bradykinin‐mediated angioedema from mast cell‐/histamine‐mediated angioedema.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 946, doi. 10.1111/all.15013
- By:
- Publication type:
- Article
Immunological effects of adjuvanted low‐dose allergoid allergen‐specific immunotherapy in experimental murine house dust mite allergy.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 907, doi. 10.1111/all.15012
- By:
- Publication type:
- Article
Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 979, doi. 10.1111/all.15011
- By:
- Publication type:
- Article
Evolution and long‐term outcomes of combined immunodeficiency due to CARMIL2 deficiency.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 1004, doi. 10.1111/all.15010
- By:
- Publication type:
- Article
Food immunotherapy practice: Nation differences across Europe, the FIND project.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 920, doi. 10.1111/all.15016
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Allergy, 2022, v. 77, n. 3, p. 719, doi. 10.1111/all.14919
- Publication type:
- Article